Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP3R

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 5, 2010, Pages 829-835

  Zhang, Kun ^a,b   Heidrich, Felix M ^a,c   DeGray, Brenda ^a   Boehmerle, Wolfgang ^a,b   Ehrlich, Barbara E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Calcium; InsP3R; NCS 1; Paclitaxel; Taxol

Indexed keywords

CALPAIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; NEURONAL CALCIUM SENSOR; PACLITAXEL; RYANODINE RECEPTOR; SHORT HAIRPIN RNA; TUBULIN MODULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART VENTRICLE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANIMALS, NEWBORN; CALCIUM SIGNALING; CALPAIN; ENZYME ACTIVATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; PACLITAXEL; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

RATTUS;

EID: 77957231606     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.08.018     Document Type: Article

References (28)

1. Walsh V., Goodman J. Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug taxol. Soc Sci Med (1982) Nov 1999, 49(9):1215-1225.
2. Schiff P.B., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277(5698):665-667.
3. Rowinsky E.K. Paclitaxel pharmacology and other tumor types. Semin Oncol Dec 1997, 24(6 Suppl 19):S19-1-S-2.
4. Woods T.C., Marks A.R. Drug-eluting stents. Annu Rev Med 2004, 55:169-178.
5. Rowinsky E.K., McGuire W.P., Guarnieri T., Fisherman J.S., Christian M.C., Donehower R.C. Cardiac disturbances during the administration of taxol. J Clin Oncol 1991, 9(9):1704-1712.
6. Gelderblom H., Verweij J., Nooter K., Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001, 37(13):1590-1598.
7. Boehmerle W., Splittgerber U., Lazarus M.B., McKenzie K.M., Johnston D.G., Austin D.J., et al. Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc Natl Acad Sci USA 2006, 103(48):18356-18361. Epub 2006 Nov 17.
8. Boehmerle W., Zhang K., Sivula M., Heidrich F.M., Lee Y., Jordt S.E., et al. Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain mediated NCS-1 degradation in neuronal cells. Proc Natl Acad Sci USA Jun 26 2007, 104(26):11103-11108.
9. Wang M.S., Davis A.A., Culver D.G., Wang Q., Powers J.C., Glass J.D. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 2004, 127(Pt 3):671-679. Epub 2004 Feb 4.
10. Clapham D.E. Calcium signaling. Cell Dec 14 2007, 131(6):1047-1058.
11. Uhlen P., Burch P.M., Zito C.I., Estrada M., Ehrlich B.E., Bennett A.M. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci USA 2006, 103(7):2160-2165. Epub 006 Feb 3.
12. Uhlen P. Spectral analysis of calcium oscillations. Sci STKE 2004, 2004(258):pl15.
13. Heidrich F.M., Zhang K., Estrada M., Huang Y., Giordano F.J., Ehrlich B.E. Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes. Circ Res May 23 2008, 102(10):1230-1238.
14. Rengifo J., Gibson C.J., Winkler E., Collin T., Ehrlich B.E. Regulation of the inositol 1,4,5-trisphosphate receptor type I by O-GlcNAc glycosylation. J Neurosci Dec 12 2007, 27(50):13813-13821.
15. Kowalski R.J., Giannakakou P., Hamel E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)). J Biol Chem 1997, 272(4):2534-2541.
16. Rodi D.J., Janes R.W., Sanganee H.J., Holton R.A., Wallace B.A., Makowski L. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol 1999, 285(1):197-203.
17. Wu X., Bers D.M. Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte. Circ Res Aug 4 2006, 99(3):283-291.
18. Schlecker C., Boehmerle W., Jeromin A., DeGray B., Varshney A., Sharma Y., et al. Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J Clin Invest 2006, 116(6):1668-1674. Epub 2006 May 11.
19. Nakamura T.Y., Sturm E., Pountney D.J., Orenzoff B., Artman M., Coetzee W.A. Developmental expression of NCS-1 (frequenin), a regulator of Kv4 K+ channels, in mouse heart. Pediatr Res 2003, 53(4):554-557. Epub 2003 Feb 20.
20. Ahuja P., Perriard E., Pedrazzini T., Satoh S., Perriard J.C., Ehler E. Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp Cell Res Apr 1 2007, 313(6):1270-1283.
21. Ter Keurs H.E., Boyden P.A. Calcium and arrhythmogenesis. Physiol Rev Apr 2007, 87(2):457-506.
22. Lakireddy V., Bub G., Baweja P., Syed A., Boutjdir M., El-Sherif N. The kinetics of spontaneous calcium oscillations and arrhythmogenesis in the in vivo heart during ischemia/reperfusion. Heart Rhythm Jan 2006, 3(1):58-66.
23. Parker K.K., Taylor L.K., Atkinson J.B., Hansen D.E., Wikswo J.P. The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias. Eur J Pharmacol Apr 6 2001, 417(1-2):131-140.
24. Poindexter B.J., Smith J.R., Buja L.M., Bick R.J. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium Dec 2001, 30(6):373-382.
25. Bergstralh D.T., Ting J.P. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev May 2006, 32(3):166-179.
26. Xia H.J., Dai D.Z., Dai Y. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats. Life Sci Oct 4 2006, 79(19):1812-1819.
27. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Aug 2006, 7(8):589-600.
28. Dolmetsch R.E., Lewis R.S., Goodnow C.C., Healy J.I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature Apr 24 1997, 386(6627):855-858.